Gordon Mortensen, MD
Pain Medicine · Milwaukee, WINPI 1407830862
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Boston Scientific at 41.2% of the total. Reporting peaked in 2020 at $8,851 and has fallen 91.7% since, to $733 in 2024.
Across 201 payments — averaging $82.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$7K
- Medtronic$6K
- Abbott$1K
- Nevro Corp.$770
- Collegium Pharmaceutical, Inc.$383
- Tersera Therapeutics LLC$354
- plus $2K from 26 others
Across 1 payment — averaging $410.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$410
What the payments were for
- Speaking & faculty fees$9,35057%
- Travel & lodging$2872%
- Food & beverage$6,89042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 32 | $6,804 |
| Medtronic(2 entities) | 29 | $5,537 |
| Abbott | 23 | $1,099 |
| Nevro Corp. | 17 | $770 |
| Collegium Pharmaceutical, Inc. | 19 | $383 |
| Tersera Therapeutics LLC | 15 | $354 |
| SPR Therapeutics, Inc | 13 | $227 |
| Vertiflex, Inc. | 3 | $227 |
| Si-bone, Inc. | 3 | $143 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $111 |
| Supernus Pharmaceuticals, Inc. | 4 | $86 |
| Scilex Pharmaceuticals Inc. | 4 | $74 |
| Biodelivery Sciences International, Inc. | 5 | $74 |
| Piramal Critical Care | 1 | $73 |
| Relievant Medsystems, Inc. | 1 | $71 |
| Ferring Pharmaceuticals Inc. | 3 | $69 |
| Fidia Pharma USA Inc. | 3 | $63 |
| Pacira Therapeutics, Inc. | 2 | $48 |
| Almatica Pharma LLC | 2 | $43 |
| Curonix LLC | 2 | $39 |
| Neuronetics, Inc. | 2 | $36 |
| Assertio Therapeutics, Inc. | 1 | $24 |
| Orthogenrx Inc. | 1 | $23 |
| Avanos Medical | 1 | $23 |
| Amgen | 1 | $20 |
| Convatec Inc. | 1 | $18 |
| Electronic Waveform Lab, Inc. | 1 | $17 |
| Davol Inc. | 1 | $16 |
| Acelrx Pharmaceuticals, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| USWM, LLC | 1 | $12 |
| GRT US Holding, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUPERION$6,377
- INTELLIS$4,147
- SYNCHROMED$545
- PROCLAIM$512
- INTELLIS ADAPTIVESTIM$343
- Omnia$255
- Senza Spinal Cord Stimulation System$136
- Senza$106
How this compares
$16,527 in reported general payments places this provider in the 85th percentile of 82 pain medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 281 | $10,868 |
| Xtampza ErOxycodone Myristate | 14 | $8,917 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 212 | $5,058 |
| BelbucaBuprenorphine Hcl | 12 | $4,913 |
| Gabapentin | 202 | $2,899 |
| Tizanidine Hcl | 111 | $1,903 |
| Pregabalin | 65 | $1,899 |
| Morphine Sulfate ErMorphine Sulfate | 51 | $1,457 |
| Lidocaine | 15 | $1,154 |
| Fentanyl | 11 | $745 |
| Methadone Hcl | 37 | $654 |
| Baclofen | 46 | $609 |
| Hydromorphone Hcl | 25 | $493 |
| Tramadol Hcl | 62 | $448 |
| Zonisamide | 20 | $410 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $383 | $13,83126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 82 pain medicine providers in Wisconsin.
Other pain medicine in Milwaukee
- Jeffrey QuintanaMilwaukee$19K
- Mei-Ying LiangMilwaukee$11K
- Eliot WickliffMilwaukee$10K
- John BruskyMilwaukee$8K
- Roman BerezovskiMilwaukee$4K
- Gwynne KirchenMilwaukee$4K
- Pamela Thomas KingMilwaukee$3K
- Michael McNettMilwaukee$1K
- Amit SinghMilwaukee$659
- Alaa Abd-ElsayedMadison$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.